Efficient Transduction of LEDGF/p75 Mutant Cells by Gain-of-Function HIV-1 Integrase Mutant Viruses

Area of Science:

• Molecular Biology
• Virology
• Gene Therapy

Background:

• Controlling retroviral DNA integration specificity is crucial for safe gene therapy vectors.
• LEDGF/p75 (Lens Equator Degeneration Factor/p75) is a lentiviral integration host cofactor.
• Previous work explored retargeting lentiviral vectors using LEDGF/p75 fusions and integrase mutants.

Purpose of the Study:

• To improve the efficiency of engineered lentiviral vectors with retargeted integration.
• To characterize a novel gain-of-function mutation in HIV-1 integrase for enhanced vector function.
• To investigate the complementary interaction between modified integrase and LEDGF/p75 variants.

Main Methods:

• Selection and characterization of gain-of-function mutations in HIV-1 integrase.
• Engineering complementary variants of LEDGF/p75.
• Assessing viral transduction efficiency of modified lentiviral vectors.
• Evaluating the impact of mutations on reverse transcription and DNA integration.

Main Results:

• A K42E mutation in HIV-1 integrase was identified as a gain-of-function mutation.
• Combining K42E and reverse-charge mutations boosted viral transduction efficiency to approximately 75% of wild-type levels.
• The integration enhancement was dependent on a complementary engineered LEDGF/p75 variant.
• While K42E improved reverse transcription and integration, only the integration boost relied on the engineered LEDGF/p75.

Conclusions:

• The optimized system enhances lentiviral retargeting specificity.
• Heterologous LEDGF/p75 fusion proteins benefit from this improved system.
• The unique complementation properties of reverse-charge integrase mutants and LEDGF/p75 host proteins are key.